Journey Medical Corporation DERM Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's operating lease right-of-use asset amortization?
- Journey Medical Corporation (DERM) reported operating lease right-of-use asset amortization of $23K in Q1 2026.
- How has Journey Medical Corporation's operating lease right-of-use asset amortization changed year-over-year?
- Journey Medical Corporation's operating lease right-of-use asset amortization increased by 9.5% year-over-year, from $21K to $23K.
- What is the long-term trend for Journey Medical Corporation's operating lease right-of-use asset amortization?
- Over 4 years (2021 to 2025), Journey Medical Corporation's operating lease right-of-use asset amortization has grown at a 0.6% compound annual growth rate (CAGR), from $86K to $88K.